Keeping Track: A Diverse Array Of Approvals, A CRL For Evolus' Botox Competitor, And Coherus Refiles Neulasta Biosimilar

11:34 EDT 20 May 2018 | SCRIP

The latest drug development news and highlights from our US FDA Performance Tracker.

More From BioPortfolio on "Keeping Track: A Diverse Array Of Approvals, A CRL For Evolus' Botox Competitor, And Coherus Refiles Neulasta Biosimilar"